Literature DB >> 16980119

Panic disorder.

Peter P Roy-Byrne1, Michelle G Craske, Murray B Stein.   

Abstract

Panic disorder is a common mental disorder that affects up to 5% of the population at some point in life. It is often disabling, especially when complicated by agoraphobia, and is associated with substantial functional morbidity and reduced quality of life. The disorder is also costly for individuals and society, as shown by increased use of health care, absenteeism, and reduced workplace productivity. Some physical illnesses (eg, asthma) commonly occur with panic disorder, and certain lifestyle factors (eg, smoking) increase the risk for the disorder, but causal pathways are still unclear. Genetic and early experiential susceptibility factors also exist, but their exact nature and pathophysiological mechanisms remain unknown. Despite an imprecise, although increased, understanding of cause, strong evidence supports the use of several effective treatments (eg, pharmacological, cognitive-behavioural). The adaptation and dissemination of these treatments to the frontlines of medical-care delivery should be urgent goals for the public-health community.

Entities:  

Mesh:

Year:  2006        PMID: 16980119     DOI: 10.1016/S0140-6736(06)69418-X

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  42 in total

1.  Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.

Authors:  Plínio C Casarotto; Ana Luisa B Terzian; Daniele C Aguiar; Hélio Zangrossi; Francisco S Guimarães; Carsten T Wotjak; Fabrício A Moreira
Journal:  Neuropsychopharmacology       Date:  2011-09-21       Impact factor: 7.853

2.  Shortness of breath and chest discomfort in a young woman: panic disorder is not always a case.

Authors:  Aibek E Mirrakhimov; Aram Barbaryan; Alaa Ali; Erwin Velasquez Kho
Journal:  BMJ Case Rep       Date:  2012-12-10

3.  Evaluating the risks of clinical research: direct comparative analysis.

Authors:  Annette Rid; Emily Abdoler; Roxann Roberson-Nay; Daniel S Pine; David Wendler
Journal:  J Child Adolesc Psychopharmacol       Date:  2014-09       Impact factor: 2.576

4.  Gray matter abnormalities in social anxiety disorder: primary, replication, and specificity studies.

Authors:  Ardesheer Talati; Spiro P Pantazatos; Franklin R Schneier; Myrna M Weissman; Joy Hirsch
Journal:  Biol Psychiatry       Date:  2012-06-29       Impact factor: 13.382

5.  Frightening Spells at Night.

Authors:  Aaron M Carlson; Jeffrey Young; Alon Avidan
Journal:  J Clin Sleep Med       Date:  2016-06-15       Impact factor: 4.062

Review 6.  Panic, suffocation false alarms, separation anxiety and endogenous opioids.

Authors:  Maurice Preter; Donald F Klein
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-08-09       Impact factor: 5.067

7.  Hippocampal hyperexcitability underlies enhanced fear memories in TgNTRK3, a panic disorder mouse model.

Authors:  Mónica Santos; Davide D'Amico; Ornella Spadoni; Alejandro Amador-Arjona; Oliver Stork; Mara Dierssen
Journal:  J Neurosci       Date:  2013-09-18       Impact factor: 6.167

8.  Panic disorder, social anxiety disorder, and a possible medical syndrome previously linked to chromosome 13.

Authors:  Ardesheer Talati; Kathryn Ponniah; Lisa J Strug; Susan E Hodge; Abby J Fyer; Myrna M Weissman
Journal:  Biol Psychiatry       Date:  2007-10-24       Impact factor: 13.382

9.  Unstable prefrontal response to emotional conflict and activation of lower limbic structures and brainstem in remitted panic disorder.

Authors:  Natalya Chechko; Renate Wehrle; Angelika Erhardt; Florian Holsboer; Michael Czisch; Philipp G Sämann
Journal:  PLoS One       Date:  2009-05-20       Impact factor: 3.240

10.  A key role for orexin in panic anxiety.

Authors:  Philip L Johnson; William Truitt; Stephanie D Fitz; Pamela E Minick; Amy Dietrich; Sonal Sanghani; Lil Träskman-Bendz; Andrew W Goddard; Lena Brundin; Anantha Shekhar
Journal:  Nat Med       Date:  2009-12-27       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.